Biotech · Private company
Theralase® Technologies Inc.
Track this companyFree. Adds Theralase® Technologies Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- Ruvidar® (TLD-1433) bladder infusion and PDTPhase 2 · Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCGClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") PatientsPHASE2 · RECRUITING · started Aug 30, 2019ClinicalTrials.gov NCT03945162 · fetched Nov 12, 2026